Granules India

Granules is a vertically-integrated pharmaceutical manufacturer that makes Finished Dosages, APIs and PFIs for brand and generics leaders around the world.

[Granules India @GranulesIndia]

Granules India is excited to be part of CPHI Milan 2026, taking place from 6-8 October 2026.
From integrated generics to complex and differentiated products, we are advancing healthcare through science, innovation and sustainable value creation.

Join us at Booth 7D18 to discover how Granules is expanding its capabilities and strengthening global partnerships.

#granulesindia #teamgranules #globalpartnerships #pharma #generics

[Granules India @GranulesIndia]

Our Q1Fy27 results are out, reflecting a strong quarter of growth and the momentum we are building.

Read more: https://t.co/S6H5ZulEJC

#financialresult #fy27 #q1fy27 #granulesindia

[Granules India @GranulesIndia]

On National Doctor’s Day, we celebrate the commitment and care of doctors who make the world a healthier place.

#NationalDoctorsDay #MedicalHeroes #TeamGranules #GranulesIndia

[Granules India @GranulesIndia]

Team Granules is excited to be at the Shanghai New International Expo Centre (SNIEC) as #CPHIChina2026 kicks off today.

Visit us at Booth E1K58 to discover how our fully integrated capabilities across APIs, PFIs, and formulations are enabling better healthcare solutions worldwide. We look forward to engaging conversations and forging new partnerships.

See you there!

#TeamGranules #GranulesIndia #Collaboration #GlobalPartnerships

[Granules India @GranulesIndia]

A more sustainable future starts with what we do today.

#worldenvironmentday #worldenvironmentday2026 #granulesindia #sustainability #climateaction #forthefuture #inspiredbynature #forclimateforourfuture

[Granules India @GranulesIndia]

Our wholly owned subsidiary, Granules Pharmaceuticals, Inc., has received the Establishment Inspection Report (EIR) from the US FDA for its Chantilly, Virginia facility, with a VAI classification.

Granules remains committed to maintaining the highest standards of quality, safety, and regulatory compliance across its facilities in India and the United States.

#granulesindia #usfda #pharmaceuticalmanufacturing #quality

[Granules India @GranulesIndia]

Granules India Limited continues to set benchmarks in Environment, Health & Safety (EHS) excellence.

We are pleased to announce that the continuous efforts of our teams at Bonthapally, Vizag, Gagillapur, and Granules Life Sciences (Shamirpet) were recognised at the CII-EHS Excellence Awards 2025, recently held in New Delhi.

#EHS #GranulesIndia #Safety #Sustainability #Recognition

[Granules India @GranulesIndia]

Granules India Limited was honoured to join global pharmaceutical leaders at India Pharma Connect, a high‑level forum hosted by the Consulate General of India in New York.

With strong operational platforms in both India and the US, such engagements are essential to delivering our commitment to global collaboration and to providing safe, effective, and affordable medicines for partners and patients.

(Photo courtesy: CGNY)

#Pharma #Global #Partnership #IndiaUS #Leadership #Innovation #GranulesIndia

[Granules India @GranulesIndia]

We are happy to welcome the 43rd batch of Pharma Pathashala, our skill-development initiative in collaboration with Swarna Bharat Trust, focused on building an industry-ready workforce for pharmaceutical manufacturing.

Since inception, Pharma Pathashala has trained 1,600+ rural youth, empowering them with practical skills, confidence, and access to meaningful employment opportunities. The goal is to to help youth from rural backgrounds rise above socio economic challenges.

#PharmaPathashala #SkillDevelopment #Inclusive #Sustainability #WomenInPharma #RuralYouth #EmpoweringYouth #GranulesIndia

[Granules India @GranulesIndia]

Over 100 Self-Directed Team (SDT) members at Granules have graduated through our ‘Learn While You Earn’ programme, an initiative that empowers the rural workforce by blending hands-on manufacturing experience with access to higher education.

This year, we are especially proud to celebrate three exceptional learners who were recognised at the School of Skill Education, Tata Institute of Social Sciences Conferment Ceremony in Mumbai.

Their journeys reminds us that transformation is inevitable when opportunity meets determination.

#PharmaManufacturing #ManufacturingExcellence #MakeInIndia #FutureOfManufacturing #IndustryReady

[CNBC-AWAAZ @CNBC_Awaaz]

#MarketOutlook | ग्रेन्यूल्स इंडिया कंपनी की आय 23 परसेंट और मुनाफा 33 परसेंट बढ़ा है

- EBITDA में भी 40 परसेंट की ग्रोथ रही है

- नतीजों और ग्रोथ आउटलुक पर कंपनी के CFO, मुकेश सुराना से चर्चा

@deepaliranaa @GranulesIndia

[Granules India @GranulesIndia]

We are heading to #CPHIChina2026!
From integrated generics to high‑entry‑barrier products, Team Granules looks forward to showcasing solutions built for scale & sustainability.

Booth E1K58 |
Date: 16–18 June
Write to us at [email protected]

#GranulesIndia #PharmaInnovation #GlobalPharma #TeamGranules #CPHI

[Granules India @GranulesIndia]

Our Q4 and Annual Result for FY26 are out.
For more details click here: https://t.co/14HdBFxjHi

#GranulesIndia #Q4 #Fy26 #FinancialResults #Pharmaceuticals #EarningsUpdate

[Granules India @GranulesIndia]

We are honoured to receive the Pharma Quality Excellence Award for Continuous Learning, recognising the learning culture we are building at Granules.

We believe our people are beating heart of Granules and they must be encouraged and empowered to achieve their highest potential and co-create opportunities for collaboration and impact.

#PharmaQualityExcellenceAwards #PQEAward #GranulesIndia #Quality #LearningCulture #EmployeeEmpowerment

[Granules India @GranulesIndia]

This #Earth Day, we reaffirm our commitment to building responsibly through innovation, efficiency, and a continued focus on sustainable practices across our operations. Driving impact today, with a long-term view for tomorrow.

#OurPowerOurPlanet #EarthDay2026 #GranulesIndia

[Granules India @GranulesIndia]

At #CPHIJapan2026, we look forward to showcasing how our sustainability roadmap can support your long term growth objectives and contribute to resilient, future ready pharmaceutical supply chains.

#GranulesIndia #CPHIJapan #SustainabilityLeadership #NetZero #Pharma #Decarbonization

[Granules India @GranulesIndia]

We were honoured to host Ms. Laura Williams, US Consul General, Ms. Meredith Metzler, Political and Economic Chief and other delegates from the US Consulate in Hyderabad, at our office.

It was an insightful exchange on strengthening India–US ties and long-term collaboration for advancing our mission to deliver safe, effective, and affordable medicines to the consumers.

#US #India #GranulesIndia

[Granules India @GranulesIndia]

On this #WorldHealthDay, we reaffirm our commitment to standing with science and working together with partners across the healthcare ecosystem to build a healthier and more resilient future for all.

#Granulesindia

[Granules India @GranulesIndia]

We are happy to share that Ms. Y. Tusharika, Ms. M. Harshitha, and Ms. K. Pratyusha - beneficiaries of the first batch of the Granules Vidya Scholarship, have successfully cleared the Union Public Service Commission (UPSC) 2025 examination.

Through our CSR initiative supporting civil service aspirants across Andhra Pradesh and Telangana, Granules has enabled access to quality study resources, mentorship, and expert coaching, empowering these young leaders to pursue their dream.

#GranulesIndia

[Granules India @GranulesIndia]

We are proud to be recognized with the International Safety Award (ISA) from the British Safety Council this year.

This award is a testament to the collective dedication of our site teams and contract partners in building and sustaining a proactive safety culture across our operations.

Together, we continue to strengthen our safety systems across our operations.

#InternationalSafetyAward #BritishSafetyCouncil #Safety #Award #Safetyfirst #GranulesIndia